Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.52 Billion HKD | -11.91% |
| 2022 | 1.73 Billion HKD | 11.24% |
| 2021 | 1.55 Billion HKD | 18.31% |
| 2020 | 1.31 Billion HKD | -8.19% |
| 2019 | 1.43 Billion HKD | -5.37% |
| 2018 | 1.51 Billion HKD | 19.58% |
| 2017 | 1.26 Billion HKD | 16.76% |
| 2016 | 1.08 Billion HKD | 11.73% |
| 2015 | 970.47 Million HKD | 27.52% |
| 2014 | 761.05 Million HKD | 23.96% |
| 2013 | 613.96 Million HKD | 84.35% |
| 2012 | 333.03 Million HKD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 332.25 Million HKD | -6.69% |
| 2024 Q2 | 332.25 Million HKD | 0.0% |
| 2023 Q1 | 406.4 Million HKD | -26.43% |
| 2023 FY | 1.52 Billion HKD | -11.91% |
| 2023 Q3 | 356.06 Million HKD | -12.39% |
| 2023 Q2 | 406.4 Million HKD | 0.0% |
| 2023 Q4 | 356.06 Million HKD | 0.0% |
| 2022 Q3 | 552.36 Million HKD | -11.81% |
| 2022 Q4 | 552.36 Million HKD | 0.0% |
| 2022 Q1 | 313.17 Million HKD | -63.25% |
| 2022 Q2 | 626.35 Million HKD | 100.0% |
| 2022 FY | 1.73 Billion HKD | 11.24% |
| 2021 FY | 1.55 Billion HKD | 18.31% |
| 2021 Q2 | 704.03 Million HKD | 100.0% |
| 2021 Q3 | 426.06 Million HKD | -39.48% |
| 2021 Q4 | 852.12 Million HKD | 100.0% |
| 2021 Q1 | 352.01 Million HKD | -52.93% |
| 2020 Q1 | 283.71 Million HKD | -53.5% |
| 2020 Q2 | 567.42 Million HKD | 100.0% |
| 2020 Q3 | 373.96 Million HKD | -34.09% |
| 2020 FY | 1.31 Billion HKD | -8.19% |
| 2020 Q4 | 747.92 Million HKD | 100.0% |
| 2019 Q4 | 610.14 Million HKD | 100.0% |
| 2019 Q2 | 822.48 Million HKD | 100.0% |
| 2019 Q1 | 411.24 Million HKD | 9.03% |
| 2019 Q3 | 305.07 Million HKD | -62.91% |
| 2019 FY | 1.43 Billion HKD | -5.37% |
| 2018 Q4 | 377.17 Million HKD | 0.0% |
| 2018 Q3 | 377.17 Million HKD | -0.79% |
| 2018 Q2 | 380.17 Million HKD | 0.21% |
| 2018 FY | 1.51 Billion HKD | 19.58% |
| 2018 Q1 | 379.36 Million HKD | 15.04% |
| 2017 Q3 | 312.46 Million HKD | 1.2% |
| 2017 FY | 1.26 Billion HKD | 16.76% |
| 2017 Q2 | 308.74 Million HKD | -1.99% |
| 2017 Q4 | 329.75 Million HKD | 5.54% |
| 2017 Q1 | 315.02 Million HKD | 14.13% |
| 2016 Q4 | 276.03 Million HKD | 3.66% |
| 2016 FY | 1.08 Billion HKD | 11.73% |
| 2016 Q3 | 266.29 Million HKD | -3.74% |
| 2016 Q2 | 276.62 Million HKD | 4.26% |
| 2016 Q1 | 265.32 Million HKD | 4.0% |
| 2015 Q2 | 250.11 Million HKD | 6.89% |
| 2015 Q4 | 255.1 Million HKD | 10.32% |
| 2015 Q3 | 231.25 Million HKD | -7.54% |
| 2015 Q1 | 233.99 Million HKD | 4.56% |
| 2015 FY | 970.47 Million HKD | 27.52% |
| 2014 Q3 | 173.22 Million HKD | -14.76% |
| 2014 Q2 | 203.22 Million HKD | 26.37% |
| 2014 Q1 | 160.81 Million HKD | -17.84% |
| 2014 FY | 761.05 Million HKD | 23.96% |
| 2014 Q4 | 223.78 Million HKD | 29.19% |
| 2013 Q1 | 122.92 Million HKD | 9.86% |
| 2013 FY | 613.96 Million HKD | 84.35% |
| 2013 Q2 | 156.33 Million HKD | 27.17% |
| 2013 Q3 | 138.96 Million HKD | -11.11% |
| 2013 Q4 | 195.73 Million HKD | 40.85% |
| 2012 FY | 333.03 Million HKD | 0.0% |
| 2012 Q4 | 111.9 Million HKD | 34.59% |
| 2012 Q1 | 65 Million HKD | 0.0% |
| 2012 Q2 | 72.99 Million HKD | 12.29% |
| 2012 Q3 | 83.14 Million HKD | 13.91% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China Healthwise Holdings Limited | 146.31 Million HKD | -942.22% |
| Tycoon Group Holdings Limited | 1.19 Billion HKD | -27.222% |